1
|
Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994; 78:761-71. [PMID: 8087844 DOI: 10.1016/s0092-8674(94)90462-6] [Citation(s) in RCA: 1958] [Impact Index Per Article: 63.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Reagents that inhibit the ubiquitin-proteasome proteolytic pathway in cells have not been available. Peptide aldehydes that inhibit major peptidase activities of the 20S and 26S proteasomes are shown to reduce the degradation of protein and ubiquitinated protein substrates by 26S particles. Unlike inhibitors of lysosomal proteolysis, these compounds inhibit the degradation of not only abnormal and short-lived polypeptides but also long-lived proteins in intact cells. We used these agents to test the importance of the proteasome in antigen presentation. When ovalbumin is introduced into the cytosol of lymphoblasts, these inhibitors block the presentation on MHC class I molecules of an ovalbumin-derived peptide by preventing its proteolytic generation. By preventing peptide production from cell proteins, these inhibitors block the assembly of class I molecules. Therefore, the proteasome catalyzes the degradation of the vast majority of cell proteins and generates most peptides presented on MHC class I molecules.
Collapse
|
Comparative Study |
31 |
1958 |
2
|
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131:485-91. [PMID: 10507956 DOI: 10.7326/0003-4819-131-7-199910050-00002] [Citation(s) in RCA: 1902] [Impact Index Per Article: 73.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Although sleep apnea is common, it often goes undiagnosed in primary care encounters. OBJECTIVE To test the Berlin Questionnaire as a means of identifying patients with sleep apnea. DESIGN Survey followed by portable, unattended sleep studies in a subset of patients. SETTING Five primary care sites in Cleveland, Ohio. PATIENTS 744 adults (of 1008 surveyed [74%]), of whom 100 underwent sleep studies. MEASUREMENTS Survey items addressed the presence and frequency of snoring behavior, waketime sleepiness or fatigue, and history of obesity or hypertension. Patients with persistent and frequent symptoms in any two of these three domains were considered to be at high risk for sleep apnea. Portable sleep monitoring was conducted to measure the number of respiratory events per hour in bed (respiratory disturbance index [RDI]). RESULTS Questions about symptoms demonstrated internal consistency (Cronbach correlations, 0.86 to 0.92). Of the 744 respondents, 279 (37.5%) were in a high-risk group that was defined a priori. For the 100 patients who underwent sleep studies, risk grouping was useful in prediction of the RDI. For example, being in the high-risk group predicted an RDI greater than 5 with a sensitivity of 0.86, a specificity of 0.77, a positive predictive value of 0.89, and a likelihood ratio of 3.79. CONCLUSION The Berlin Questionnaire provides a means of identifying patients who are likely to have sleep apnea.
Collapse
|
|
26 |
1902 |
3
|
Klement G, Baruchel S, Rak J, Man S, Clark K, Hicklin DJ, Bohlen P, Kerbel RS. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 2000; 105:R15-24. [PMID: 10772661 PMCID: PMC517491 DOI: 10.1172/jci8829] [Citation(s) in RCA: 840] [Impact Index Per Article: 33.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/1999] [Accepted: 02/25/2000] [Indexed: 12/16/2022] Open
Abstract
Various conventional chemotherapeutic drugs can block angiogenesis or even kill activated, dividing endothelial cells. Such effects may contribute to the antitumor efficacy of chemotherapy in vivo and may delay or prevent the acquisition of drug-resistance by cancer cells. We have implemented a treatment regimen that augments the potential antivascular effects of chemotherapy, that is devoid of obvious toxic side effects, and that obstructs the development of drug resistance by tumor cells. Xenografts of 2 independent neuroblastoma cell lines were subjected to either continuous treatment with low doses of vinblastine, a monoclonal neutralizing antibody (DC101) targeting the flk-1/KDR (type 2) receptor for VEGF, or both agents together. The rationale for this combination was that any antivascular effects of the low-dose chemotherapy would be selectively enhanced in cells of newly formed vessels when survival signals mediated by VEGF are blocked. Both DC101 and low-dose vinblastine treatment individually resulted in significant but transient xenograft regression, diminished tumor vascularity, and direct inhibition of angiogenesis. Remarkably, the combination therapy resulted in full and sustained regressions of large established tumors, without an ensuing increase in host toxicity or any signs of acquired drug resistance during the course of treatment, which lasted for >6 months. This article may have been published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.
Collapse
MESH Headings
- Animals
- Antibodies, Monoclonal/adverse effects
- Antibodies, Monoclonal/therapeutic use
- Antineoplastic Agents, Phytogenic/adverse effects
- Antineoplastic Agents, Phytogenic/therapeutic use
- Cells, Cultured
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Fluorescence
- Humans
- Mice
- Mice, SCID
- Neoplasm Transplantation
- Neovascularization, Pathologic
- Neuroblastoma/blood supply
- Neuroblastoma/drug therapy
- Neuroblastoma/pathology
- Receptor Protein-Tyrosine Kinases/immunology
- Receptors, Growth Factor/immunology
- Receptors, Vascular Endothelial Growth Factor
- Tumor Cells, Cultured
- Vinblastine/adverse effects
- Vinblastine/therapeutic use
Collapse
|
research-article |
25 |
840 |
4
|
Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 1999; 159:1527-32. [PMID: 10228121 DOI: 10.1164/ajrccm.159.5.9809079] [Citation(s) in RCA: 771] [Impact Index Per Article: 29.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
This study examined risk factors for sleep-disordered breathing (SDB) in children and adolescents; specifically, quantifying risk associated with obesity, race, and upper and lower respiratory problems. Subjects were participants in a genetic-epidemiologic study of SDB and included 399 children and adolescents 2 to 18 yr of age, recruited as members of families with a member (a proband) with known sleep apnea (31 index families) or as members of neighborhood control families (30 families). SDB was assessed with home overnight multichannel monitoring and SDB was defined based on an apneahypopnea index >/= 10 (moderately affected) or < 5 (unaffected). SDB of moderate level was significantly associated with obesity (odds ratio, 4.59; 95% confidence interval [CI], 1.58 to 13.33) and African-American race (odds ratio, 3.49; 95% CI, 1.56 to 8.32) but not with sex or age. After adjusting for obesity, proband sampling, race and familial clustering, sinus problems and persistent wheeze each independently (of the other) predicted SDB. These data suggest the importance of upper and lower respiratory problems and obesity as risk factors for SDB in children and adolescents. Increased risk in African Americans appears to be independent of the effects of obesity or respiratory problems.
Collapse
|
|
26 |
771 |
5
|
Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millán JL, Gamble V, Harris PC. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995; 10:151-60. [PMID: 7663510 DOI: 10.1038/ng0695-151] [Citation(s) in RCA: 636] [Impact Index Per Article: 21.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Characterization of the polycystic kidney disease 1 (PKD1) gene has been complicated by genomic rearrangements on chromosome 16. We have used an exon linking strategy, taking RNA from a cell line containing PKD1 but not the duplicate loci, to clone a cDNA contig of the entire transcript. The transcript consists of 14,148 bp (including a correction to the previously described C terminus), distributed among 46 exons spanning 52 kb. The predicted PKD1 protein, polycystin, is a glycoprotein with multiple transmembrane domains and a cytoplasmic C-tail. The N-terminal extracellular region of over 2,500 aa contains leucine-rich repeats, a C-type lectin, 16 immunoglobulin-like repeats and four type III fibronectin-related domains. Our results indicate that polycystin is an integral membrane protein involved in cell-cell/matrix interactions.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Base Sequence
- Cattle
- Chromosome Mapping
- Chromosomes, Human, Pair 16
- Cloning, Molecular
- Computer Simulation
- DNA, Complementary/analysis
- Fibronectins/genetics
- Humans
- Membrane Glycoproteins/biosynthesis
- Membrane Glycoproteins/chemistry
- Membrane Glycoproteins/genetics
- Models, Molecular
- Molecular Sequence Data
- Polycystic Kidney, Autosomal Dominant/chemistry
- Polycystic Kidney, Autosomal Dominant/genetics
- Polycystic Kidney, Autosomal Dominant/metabolism
- Protein Biosynthesis
- Protein Conformation
- Proteins/chemistry
- Proteins/genetics
- Rats
- Repetitive Sequences, Nucleic Acid
- Sequence Homology, Amino Acid
- TRPP Cation Channels
Collapse
|
Comparative Study |
30 |
636 |
6
|
Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A 1993; 90:4942-6. [PMID: 8506338 PMCID: PMC46629 DOI: 10.1073/pnas.90.11.4942] [Citation(s) in RCA: 434] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Antigens in extracellular fluids can be processed and presented with major histocompatibility complex (MHC) class I molecules by a subset of antigen presenting cells (APCs). Chicken egg ovalbumin (Ova) linked to beads was presented with MHC class I molecules by these cells up to 10(4)-fold more efficiently than soluble Ova. This enhanced presentation was observed with covalently or noncovalently linked Ova and with beads of different compositions. A key parameter in the activity of these conjugates was the size of the beads. The APC that is responsible for this form of presentation is a macrophage. These cells internalize the antigen constructs through phagocytosis, since cytochalasin B inhibited presentation. Processing of the antigen and association with MHC class I molecules appears to occur intracellularly as presentation was observed under conditions where there was no detectable release of peptides into the extracellular fluids. When injected in vivo in C57BL/6 mice, Ova-beads, but not soluble Ova, primed CD4- CD8+ cytotoxic T lymphocytes (CTLs). Similar results were obtained in BALB/c mice immunized with beta-galactosidase-beads. The implications of these findings for development of nonliving vaccines that stimulate CTL immunity are discussed.
Collapse
|
research-article |
32 |
434 |
7
|
Abstract
Over an 8 year period, 170 patients with multiple sclerosis (MS) and 134 healthy controls were assessed at monthly intervals in order to ascertain environmental factors which might be important in producing exacerbation or progression of the illness, and to compare the frequency of common viral infections in the two groups. During cumulative periods designated "at risk" (2 weeks before the onset of infection until 5 weeks afterwards) annual exacerbation rates were almost 3-fold greater than those during periods not at risk. Approximately 9% of infections were temporally related to exacerbations, whereas 27% of exacerbations were related to infections. Frequency of common infections was approximately 20-50% less in MS patients than controls; it was progressively less in those with greater disability. Even in minimally disabled patients with similar potential for infectious contacts, the infection rate was significantly less than in controls, suggesting that MS patients could have superior immune defences against common viruses.
Collapse
|
research-article |
40 |
411 |
8
|
Jakicic JM, Clark K, Coleman E, Donnelly JE, Foreyt J, Melanson E, Volek J, Volpe SL. American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2001; 33:2145-56. [PMID: 11740312 DOI: 10.1097/00005768-200112000-00026] [Citation(s) in RCA: 410] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
In excess of 55% of adults in the United States are classified as either overweight (body mass index = 25-29.9 kg.m(-2)) or obese (body mass index > or = 30 kg.m(-2)). To address this significant public health problem, the American College of Sports Medicine recommends that the combination of reductions in energy intake and increases in energy expenditure, through structured exercise and other forms of physical activity, be a component of weight loss intervention programs. An energy deficit of 500-1000 kcal.d-1 achieved through reductions in total energy intake is recommended. Moreover, it appears that reducing dietary fat intake to <30% of total energy intake may facilitate weight loss by reducing total energy intake. Although there may be advantages to modifying protein and carbohydrate intake, the optimal doses of these macronutritents for weight loss have not been determined. Significant health benefits can be recognized with participation in a minimum of 150 min (2.5 h) of moderate intensity exercise per week, and overweight and obese adults should progressively increase to this initial exercise goal. However, there may be advantages to progressively increasing exercise to 200-300 min (3.3-5 h) of exercise per week, as recent scientific evidence indicates that this level of exercise facilitates the long-term maintenance of weight loss. The addition of resistance exercise to a weight loss intervention will increase strength and function but may not attenuate the loss of fat-free mass typically observed with reductions in total energy intake and loss of body weight. When medically indicated, pharmacotherapy may be used for weight loss, but pharmacotherapy appears to be most effective when used in combination with modifications of both eating and exercise behaviors. The American College of Sports Medicine recommends that the strategies outlined in this position paper be incorporated into interventions targeting weight loss and the prevention of weight regain for adults.
Collapse
|
Guideline |
24 |
410 |
9
|
Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, Thorp JM, Caritis SN, Prasad M, Tita AT, Saade GR, Sorokin Y, Rouse DJ, Blackwell SC, Tolosa JE, Varner M, Hill K, Sowles A, Postma J, Alexander S, Andersen G, Scott V, Morby V, Jolley K, Miller J, Berg B, Talucci M, Zylfijaj M, Reid Z, Leed R, Benson J, Forester S, Kitto C, Davis S, Falk M, Perez C, Dorman K, Mitchell J, Kaluta E, Clark K, Spicer K, Timlin S, Wilson K, Leveno K, Moseley L, Santillan M, Price J, Buentipo K, Bludau V, Thomas T, Fay L, Melton C, Kingsbery J, Benezue R, Simhan H, Bickus M, Fischer D, Kamon T, DeAngelis D, Mercer B, Milluzzi C, Dalton W, Dotson T, McDonald P, Brezine C, McGrail A, Latimer C, Guzzo L, Johnson F, Gerwig L, Fyffe S, Loux D, Frantz S, Cline D, Wylie S, Iams J, Wallace M, Northen A, Grant J, Colquitt C, Rouse D, Andrews W, Mallett G, Ramos-Brinson M, Roy A, Stein L, Campbell P, Collins C, Jackson N, Dinsmoor M, Senka J, Paychek K, Peaceman A, Moss J, Salazar A, Acosta A, Hankins G, Hauff N, Palmer L, Lockhart P, Driscoll D, Wynn L, Sudz C, Dengate D, Girard C, Field S, Breault P, Smith F, Annunziata N, Allard D, Silva J, Gamage M, Hunt J, Tillinghast J, Corcoran N, Jimenez M, Ortiz F, Givens P, Rech B, Moran C, Hutchinson M, Spears Z, Carreno C, Heaps B, Zamora G, Seguin J, Rincon M, Snyder J, Farrar C, Lairson E, Bonino C, Smith W, Beach K, Van Dyke S, Butcher S, Thom E, Zhao Y, McGee P, Momirova V, Palugod R, Reamer B, Larsen M, Williams T, Spangler T, Lozitska A, Spong C, Tolivaisa S, VanDorsten J. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol 2016; 215:103.e1-103.e14. [PMID: 26772790 PMCID: PMC4921282 DOI: 10.1016/j.ajog.2016.01.004] [Citation(s) in RCA: 343] [Impact Index Per Article: 38.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2015] [Revised: 12/28/2015] [Accepted: 01/02/2016] [Indexed: 11/25/2022]
Abstract
BACKGROUND Although preterm birth <37 weeks' gestation is the leading cause of neonatal morbidity and mortality in the United States, the majority of data regarding preterm neonatal outcomes come from older studies, and many reports have been limited to only very preterm neonates. Delineation of neonatal outcomes by delivery gestational age is needed to further clarify the continuum of mortality and morbidity frequencies among preterm neonates. OBJECTIVE We sought to describe the contemporary frequencies of neonatal death, neonatal morbidities, and neonatal length of stay across the spectrum of preterm gestational ages. STUDY DESIGN This was a secondary analysis of an obstetric cohort of 115,502 women and their neonates who were born in 25 hospitals nationwide, 2008 through 2011. All liveborn nonanomalous singleton preterm (23.0-36.9 weeks of gestation) neonates were included in this analysis. The frequency of neonatal death, major neonatal morbidity (intraventricular hemorrhage grade III/IV, seizures, hypoxic-ischemic encephalopathy, necrotizing enterocolitis stage II/III, bronchopulmonary dysplasia, persistent pulmonary hypertension), and minor neonatal morbidity (hypotension requiring treatment, intraventricular hemorrhage grade I/II, necrotizing enterocolitis stage I, respiratory distress syndrome, hyperbilirubinemia requiring treatment) were calculated by delivery gestational age; each neonate was classified once by the worst outcome for which criteria was met. RESULTS In all, 8334 deliveries met inclusion criteria. There were 119 (1.4%) neonatal deaths. In all, 657 (7.9%) neonates had major morbidity, 3136 (37.6%) had minor morbidity, and 4422 (53.1%) survived without any of the studied morbidities. Deaths declined rapidly with each advancing week of gestation. This decline in death was accompanied by an increase in major neonatal morbidity, which peaked at 54.8% at 25 weeks of gestation. As frequencies of death and major neonatal morbidity fell, minor neonatal morbidity increased, peaking at 81.7% at 31 weeks of gestation. The frequency of all morbidities fell >32 weeks. After 25 weeks, neonatal length of hospital stay decreased significantly with each additional completed week of pregnancy; among babies delivered from 26-32 weeks of gestation, each additional week in utero reduced the subsequent length of neonatal hospitalization by a minimum of 8 days. The median postmenstrual age at discharge nadired around 36 weeks' postmenstrual age for babies born at 31-35 weeks of gestation. CONCLUSION Our data show that there is a continuum of outcomes, with each additional week of gestation conferring survival benefit while reducing the length of initial hospitalization. These contemporary data can be useful for patient counseling regarding preterm outcomes.
Collapse
|
Research Support, N.I.H., Extramural |
9 |
343 |
10
|
Pascual-Leone A, Grafman J, Clark K, Stewart M, Massaquoi S, Lou JS, Hallett M. Procedural learning in Parkinson's disease and cerebellar degeneration. Ann Neurol 1993; 34:594-602. [PMID: 8215247 DOI: 10.1002/ana.410340414] [Citation(s) in RCA: 314] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
We compared procedural learning, translation of procedural knowledge into declarative knowledge, and use of declarative knowledge in age-matched normal volunteers (n = 30), patients with Parkinson's disease (n = 20), and patients with cerebellar degeneration (n = 15) by using a serial reaction time task. Patients with Parkinson's disease achieved procedural knowledge and used declarative knowledge of the task to improve performance, but they required a larger number of repetitions of the task to translate procedural knowledge into declarative knowledge. Patients with cerebellar degeneration did not show performance improvement due to procedural learning, failed to achieve declarative knowledge, and showed limited use of declarative knowledge of the task to improve their performance. Both basal ganglia and cerebellum are involved in procedural learning, but their roles are different. The normal influence of the basal ganglia on the prefrontal cortex may be required for timely access of information to and from the working memory buffer, while the cerebellum may index and order events in the time domain and be therefore essential for any cognitive functions involving sequences.
Collapse
|
|
32 |
314 |
11
|
Bell KS, Sebaihia M, Pritchard L, Holden MTG, Hyman LJ, Holeva MC, Thomson NR, Bentley SD, Churcher LJC, Mungall K, Atkin R, Bason N, Brooks K, Chillingworth T, Clark K, Doggett J, Fraser A, Hance Z, Hauser H, Jagels K, Moule S, Norbertczak H, Ormond D, Price C, Quail MA, Sanders M, Walker D, Whitehead S, Salmond GPC, Birch PRJ, Parkhill J, Toth IK. Genome sequence of the enterobacterial phytopathogen Erwinia carotovora subsp. atroseptica and characterization of virulence factors. Proc Natl Acad Sci U S A 2004; 101:11105-10. [PMID: 15263089 PMCID: PMC503747 DOI: 10.1073/pnas.0402424101] [Citation(s) in RCA: 291] [Impact Index Per Article: 13.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2004] [Indexed: 11/18/2022] Open
Abstract
The bacterial family Enterobacteriaceae is notable for its well studied human pathogens, including Salmonella, Yersinia, Shigella, and Escherichia spp. However, it also contains several plant pathogens. We report the genome sequence of a plant pathogenic enterobacterium, Erwinia carotovora subsp. atroseptica (Eca) strain SCRI1043, the causative agent of soft rot and blackleg potato diseases. Approximately 33% of Eca genes are not shared with sequenced enterobacterial human pathogens, including some predicted to facilitate unexpected metabolic traits, such as nitrogen fixation and opine catabolism. This proportion of genes also contains an overrepresentation of pathogenicity determinants, including possible horizontally acquired gene clusters for putative type IV secretion and polyketide phytotoxin synthesis. To investigate whether these gene clusters play a role in the disease process, an arrayed set of insertional mutants was generated, and mutations were identified. Plant bioassays showed that these mutants were significantly reduced in virulence, demonstrating both the presence of novel pathogenicity determinants in Eca, and the impact of functional genomics in expanding our understanding of phytopathogenicity in the Enterobacteriaceae.
Collapse
|
research-article |
21 |
291 |
12
|
Aartsen MG, Abraham K, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Archinger M, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Tjus JB, Becker KH, Beiser E, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Braun J, Brayeur L, Bretz HP, Brown AM, Buzinsky N, Casey J, Casier M, Cheung E, Chirkin D, Christov A, Christy B, Clark K, Classen L, Coenders S, Cowen DF, Silva AHC, Daughhetee J, Davis JC, Day M, André JPAMD, Clercq CD, Dembinski H, Ridder SD, Desiati P, Vries KDD, Wasseige GD, With MD, DeYoung T, Díaz-Vélez JC, Dumm JP, Dunkman M, Eagan R, Eberhardt B, Ehrhardt T, Eichmann B, Euler S, Evenson PA, Fadiran O, Fahey S, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Fuchs T, Gaisser TK, Gaior R, Gallagher J, Gerhardt L, Ghorbani K, Gier D, Gladstone L, Glagla M, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grant D, Gretskov P, Groh JC, Gross A, Ha C, Haack C, Ismail AH, Hallgren A, Halzen F, Hansmann B, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hellwig D, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Holzapfel K, Homeier A, Hoshina K, Huang F, Huber M, Huelsnitz W, Hulth PO, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze GS, Jero K, Jurkovic M, Kaminsky B, Kappes A, Karg T, Karle A, Kauer M, Keivani A, Kelley JL, Kemp J, Kheirandish A, Kiryluk J, Kläs J, Klein SR, Kohnen G, Kolanoski H, Konietz R, Koob A, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krings K, Kroll G, Kroll M, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Lanfranchi JL, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leuner J, Lünemann J, Madsen J, Maggi G, Mahn KBM, Maruyama R, Mase K, Matis HS, Maunu R, McNally F, Meagher K, Medici M, Meli A, Menne T, Merino G, Meures T, Miarecki S, Middell E, Middlemas E, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Olivas A, Omairat A, O’Murchadha A, Palczewski T, Paul L, Pepper JA, Heros CPDL, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Pütz J, Quinnan M, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Relich M, Resconi E, Rhode W, Richman M, Richter S, Riedel B, Robertson S, Rongen M, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Sabbatini L, Sander HG, Sandrock A, Sandroos J, Sarkar S, Schatto K, Scheriau F, Schimp M, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Seckel D, Seunarine S, Shanidze R, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stahlberg M, Stamatikos M, Stanev T, Stanisha NA, Stasik A, Stezelberger T, Stokstad RG, Stössl A, Strahler EA, Ström R, Strotjohann NL, Sullivan GW, Sutherland M, Taavola H, Taboada I, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Tosi D, Tselengidou M, Unger E, Usner M, Vallecorsa S, Vandenbroucke J, Eijndhoven NV, Vanheule S, Santen JV, Veenkamp J, Vehring M, Voge M, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandkowsky N, Weaver C, Wendt C, Westerhoff S, Whelan BJ, Whitehorn N, Wichary C, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Zoll M. A COMBINED MAXIMUM-LIKELIHOOD ANALYSIS OF THE HIGH-ENERGY ASTROPHYSICAL NEUTRINO FLUX MEASURED WITH ICECUBE. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-637x/809/1/98] [Citation(s) in RCA: 288] [Impact Index Per Article: 28.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
|
10 |
288 |
13
|
Robinson CM, Goudie EB, Murray IR, Jenkins PJ, Ahktar MA, Read EO, Foster CJ, Clark K, Brooksbank AJ, Arthur A, Crowther MA, Packham I, Chesser TJ. Open reduction and plate fixation versus nonoperative treatment for displaced midshaft clavicular fractures: a multicenter, randomized, controlled trial. J Bone Joint Surg Am 2013; 95:1576-84. [PMID: 24005198 DOI: 10.2106/jbjs.l.00307] [Citation(s) in RCA: 278] [Impact Index Per Article: 23.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
BACKGROUND There is a growing trend to treat displaced midshaft clavicular fractures with primary open reduction and plate fixation; whether such treatment results in improved patient outcomes is debatable. The aim of this multicenter, single-blinded, randomized controlled trial was to compare union rates, functional outcomes, and economic costs for displaced midshaft clavicular fractures that were treated with either primary open reduction and plate fixation or nonoperative treatment. METHODS In a prospective, multicenter, stratified, randomized controlled trial, 200 patients between sixteen and sixty years of age who had an acute displaced midshaft clavicular fracture were randomized to receive either primary open reduction and plate fixation or nonoperative treatment. Functional assessment was conducted at six weeks, three months, six months, and one year with use of the Disabilities of the Arm, Shoulder and Hand (DASH) and Constant scores. Union was evaluated with use of three-dimensional computed tomography. Complications were recorded, and an economic evaluation was performed. RESULTS The rate of nonunion was significantly reduced after open reduction and plate fixation (one nonunion) as compared with nonoperative treatment (sixteen nonunions) (relative risk = 0.07; p = 0.007). Group allocation to nonoperative treatment was independently predictive of the development of nonunion (p = 0.0001). Overall, DASH and Constant scores were significantly better after open reduction and plate fixation than after nonoperative treatment at the time of the one-year follow-up (DASH score, 3.4 versus 6.1 [p = 0.04]; Constant score, 92.0 versus 87.8 [p = 0.01]). However, when patients with nonunion were excluded from analysis, there were no significant differences in the Constant scores or DASH scores at any time point. Patients were less dissatisfied with symptoms of shoulder droop, local bump at the fracture site, and shoulder asymmetry in the open reduction and plate fixation group (p < 0.0001). The cost of treatment was significantly greater after open reduction and plate fixation (p < 0.0001). CONCLUSIONS Open reduction and plate fixation reduces the rate of nonunion after acute displaced midshaft clavicular fracture compared with nonoperative treatment and is associated with better functional outcomes. However, the improved outcomes appear to result from the prevention of nonunion by open reduction and plate fixation. Open reduction and plate fixation is more expensive and is associated with implant-related complications that are not seen in association with nonoperative treatment. The results of the present study do not support routine primary open reduction and plate fixation for the treatment of displaced midshaft clavicular fractures.
Collapse
|
Multicenter Study |
12 |
278 |
14
|
Abstract
Depression has been reported to be common in patients with coronary artery disease (CAD), using a variety of criteria for the diagnosis of depression. However, many studies have relied solely on the presence of symptoms such as a dysphoric mood and fatigue in making a diagnosis of depression. Both fatigue and dysphoric mood are also associated with medical illnesses, and psychiatric diagnoses based on such nonspecific symptoms may lack the specificity necessary to predict the need for psychiatric treatment. To assess the incidence of depression likely to require and respond to psychiatric treatment, 50 patients documented to have CAD by coronary angiography underwent psychiatric diagnostic interviews. Current research-based criteria (DSM-III) were used to make diagnoses of major depressive disorder. In addition, the applicability of a brief screening inventory the (Beck depression inventory) for detecting the presence of depression in these patients was tested. Nine patients (18%) met criteria (DSM-III) for major depressive episode. Depression was not related to the extent of CAD, age or use of beta blockers. There was a relation between depression and smoking. Only 2 of the 9 depressed patients had been diagnosed previously and were being treated for depression. When a score of greater than or equal to 10 on the Beck depression inventory was used to distinguish patients with depression, it had moderate sensitivity (78%) and specificity (90%) for the identification of depression.
Collapse
|
|
38 |
258 |
15
|
Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K, Yu KT, Jaye M, Ivashchenko Y. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 2001; 8:367-76. [PMID: 11550088 DOI: 10.1038/sj.cdd.4400810] [Citation(s) in RCA: 254] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2000] [Revised: 10/25/2000] [Accepted: 11/08/2000] [Indexed: 11/09/2022] Open
Abstract
It has been shown that oxygen deprivation results in apoptotic cell death, and that hypoxia inducible factor 1 (HIF1) and the tumor suppressor p53 play key roles in this process. However, the molecular mechanism through which hypoxia and HIF1 induce apoptosis is not clear. Here we show that the expression of pro-apoptotic gene BNIP3 is dramatically induced by hypoxia in various cell types, including primary rat neonatal cardiomyocytes. Overexpression of HIF1alpha, but not p53, induces the expression of BNIP3. Overexpression of BNIP3 leads to a rather unusual type of apoptosis, as no cytochrome c leakage from mitochondria was detected and inhibitors of caspases were unable to prevent cell death. Taken together, these data suggest that HIF1-dependent induction of BNIP3 may play a significant role during hypoxia-induced cell death.
Collapse
|
|
24 |
254 |
16
|
Jaju RJ, Fidler C, Haas OA, Strickson AJ, Watkins F, Clark K, Cross NC, Cheng JF, Aplan PD, Kearney L, Boultwood J, Wainscoat JS. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood 2001; 98:1264-7. [PMID: 11493482 DOI: 10.1182/blood.v98.4.1264] [Citation(s) in RCA: 187] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The recurrent translocation t(5;11)(q35;p15.5) associated with a 5q deletion, del(5q), has been reported in childhood acute myeloid leukemia (AML). We report the cloning of the translocation breakpoints in de novo childhood AML harboring a cryptic t(5;11)(q35;p15.5). Fluorescence in situ hybridization (FISH) analysis demonstrated that the nucleoporin gene (NUP98) at 11p15.5 was disrupted by this translocation. By using 3'--rapid amplification of complementary DNA ends (3'-RACE) polymerase chain reaction, we identified a chimeric messenger RNA that results in the in-frame fusion of NUP98 to a novel gene, NSD1. The NSD1 gene has 2596 amino acid residues and a 85% homology to the murine Nsd1 with the domain structure being conserved. The NSD1 gene was localized to 5q35 by FISH and is widely expressed. The reciprocal transcript, NSD1-NUP98, was also detected by reverse transcriptase--polymerase chain reaction. This is the first report in which the novel gene NSD1 has been implicated in human malignancy. (Blood. 2001;98:1264-1267)
Collapse
|
|
24 |
187 |
17
|
Aartsen MG, Abbasi R, Abdou Y, Ackermann M, Adams J, Aguilar JA, Ahlers M, Altmann D, Auffenberg J, Bai X, Baker M, Barwick SW, Baum V, Bay R, Beatty JJ, Bechet S, Becker Tjus J, Becker KH, Benabderrahmane ML, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Bertrand D, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohaichuk S, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Bruijn R, Brunner J, Carson M, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Clevermann F, Coenders S, Cohen S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, Day M, De Clercq C, De Ridder S, Desiati P, de Vries KD, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eichmann B, Eisch J, Ellsworth RW, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grandmont DT, Grant D, Groß A, Ha C, Haj Ismail A, Hallen P, Hallgren A, Halzen F, Hanson K, Heereman D, Heinen D, Helbing K, Hellauer R, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Jagielski K, Japaridze GS, Jero K, Jlelati O, Kaminsky B, Kappes A, Karg T, Karle A, Kelley JL, Kiryluk J, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krasberg M, Krings K, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Landsman H, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leute J, Lünemann J, Madsen J, Maggi G, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Merck M, Meures T, Miarecki S, Middell E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, O'Murchadha A, Paul L, Pepper JA, Pérez de los Heros C, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Resconi E, Rhode W, Ribordy M, Richman M, Riedel B, Rodrigues JP, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Salameh T, Sander HG, Santander M, Sarkar S, Schatto K, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Sestayo Y, Seunarine S, Shanidze R, Sheremata C, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Sullivan GW, Taavola H, Taboada I, Tamburro A, Tepe A, Ter-Antonyan S, Tešić G, Tilav S, Toale PA, Toscano S, Unger E, Usner M, van Eijndhoven N, Van Overloop A, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Waldenmaier T, Wallraff M, Weaver C, Wellons M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zoll M. Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science 2013; 342:1242856. [PMID: 24264993 DOI: 10.1126/science.1242856] [Citation(s) in RCA: 181] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
We report on results of an all-sky search for high-energy neutrino events interacting within the IceCube neutrino detector conducted between May 2010 and May 2012. The search follows up on the previous detection of two PeV neutrino events, with improved sensitivity and extended energy coverage down to about 30 TeV. Twenty-six additional events were observed, substantially more than expected from atmospheric backgrounds. Combined, both searches reject a purely atmospheric origin for the 28 events at the 4σ level. These 28 events, which include the highest energy neutrinos ever observed, have flavors, directions, and energies inconsistent with those expected from the atmospheric muon and neutrino backgrounds. These properties are, however, consistent with generic predictions for an additional component of extraterrestrial origin.
Collapse
|
Research Support, U.S. Gov't, Non-P.H.S. |
12 |
181 |
18
|
Leeuw T, Fourest-Lieuvin A, Wu C, Chenevert J, Clark K, Whiteway M, Thomas DY, Leberer E. Pheromone response in yeast: association of Bem1p with proteins of the MAP kinase cascade and actin. Science 1995; 270:1210-3. [PMID: 7502048 DOI: 10.1126/science.270.5239.1210] [Citation(s) in RCA: 170] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Haploid cells of the yeast Saccharomyces cerevisiae respond to mating pheromones with polarized growth toward the mating partner. This morphological response requires the function of the cell polarity establishment protein Bem1p. Immunochemical and two-hybrid protein interaction assays revealed that Bem1p interacts with two components of the pheromone-responsive mitogen-activated protein (MAP) kinase cascade, Ste20p and Ste5p, as well as with actin. Mutants of Bem1p that are associated with defective pheromone-induced polarized morphogenesis interacted with Ste5p and actin but not with Ste20p. Thus, the association of Bem1p with Ste20p and Ste5p may contribute to the conveyance of spatial information that regulates polarized rearrangement of the actin cytoskeleton during yeast mating.
Collapse
|
|
30 |
170 |
19
|
Smith JS, Fishbein DB, Rupprecht CE, Clark K. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 1991; 324:205-11. [PMID: 1985241 DOI: 10.1056/nejm199101243240401] [Citation(s) in RCA: 168] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
BACKGROUND Extensive investigation of three patients who died of rabies in the United States failed to reveal any source of exposure to the disease. The three patients had immigrated to the United States from areas in Laos, the Philippines, and Mexico where rabies is endemic. METHODS We studied rabies viruses isolated from the three patients, other patients with a known source of exposure, and animals in the United States, Thailand (as a proxy for Laos), the Philippines, and Mexico. The viruses were characterized by indirect immunofluorescence and neutralization tests according to their reactions to panels of monoclonal antibodies. Transcribed complementary DNA from these isolates was amplified by the polymerase chain reaction; the DNA product was then analyzed by differential digestion with restriction enzymes. RESULTS The viral isolate from each of the three patients was a rabies variant with distinctive antigenic or genetic characteristics. For each of the three isolates, identical variants were found in specimens from rabid animals obtained from or near the country in which the patient lived before immigrating to the United States. None of these variants were found among the isolates collected from rabid animals in the United States. CONCLUSIONS Rabies infection in these three patients did not originate in the United States but resulted from exposures in Laos, the Philippines, and Mexico. Since the three patients had lived in the United States for 4 years, 6 years, and 11 months, our findings suggest that the onset of the clinical manifestations of rabies occurred after long incubation periods.
Collapse
|
Case Reports |
34 |
168 |
20
|
Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 1988; 32:159-64. [PMID: 3404497 DOI: 10.1016/0022-3999(88)90050-5] [Citation(s) in RCA: 153] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Seventy-seven patients undergoing elective cardiac catheterization were administered a diagnostic psychiatric interview and their mean heart rates and heart rate variability were determined from the results of a 24 hr ambulatory ECG. The mean heart rate for depressed patients with coronary artery disease (CAD) was significantly higher than for nondepressed CAD patients, independent of the patient's age, smoking status, and beta blocker therapy. Heart rate variability was lower in depressed patients but did not achieve significance. With the exception of smoking, which was more common in depressed patients, there were no significant differences between the depressed and nondepressed patients on any other medical or demographic variable assessed. It is concluded that elevated heart rate may represent increased sympathetic tone in depressed CAD patients, and may help to explain the increased morbidity and mortality reported in these patients.
Collapse
|
|
37 |
153 |
21
|
Aartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Classen L, Clevermann F, Coenders S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, Day M, de André JPAM, De Clercq C, De Ridder S, Desiati P, de Vries KD, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eichmann B, Eisch J, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gier D, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grandmont DT, Grant D, Gretskov P, Groh JC, Groß A, Ha C, Haack C, Haj Ismail A, Hallen P, Hallgren A, Halzen F, Hanson K, Hebecker D, Heereman D, Heinen D, Helbing K, Hellauer R, Hellwig D, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huang F, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Jagielski K, Japaridze GS, Jero K, Jlelati O, Jurkovic M, Kaminsky B, Kappes A, Karg T, Karle A, Kauer M, Kelley JL, Kheirandish A, Kiryluk J, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Koob A, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Kriesten A, Krings K, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Larsen DT, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leute J, Lünemann J, Macías O, Madsen J, Maggi G, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Meli A, Meures T, Miarecki S, Middell E, Middlemas E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, Omairat A, O'Murchadha A, Palczewski T, Paul L, Penek O, Pepper JA, Pérez de Los Heros C, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Pütz J, Quinnan M, Rädel L, Rameez M, Rawlins K, Redl P, Rees I, Reimann R, Resconi E, Rhode W, Richman M, Riedel B, Robertson S, Rodrigues JP, Rongen M, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Sander HG, Santander M, Sarkar S, Schatto K, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Sestayo Y, Seunarine S, Shanidze R, Sheremata C, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stanisha NA, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Strotjohann NL, Sullivan GW, Taavola H, Taboada I, Tamburro A, Tepe A, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Tosi D, Tselengidou M, Unger E, Usner M, Vallecorsa S, van Eijndhoven N, Vandenbroucke J, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Wallraff M, Weaver C, Wellons M, Wendt C, Westerhoff S, Whelan BJ, Whitehorn N, Wichary C, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zoll M. Observation of high-energy astrophysical neutrinos in three years of IceCube data. PHYSICAL REVIEW LETTERS 2014; 113:101101. [PMID: 25238345 DOI: 10.1103/physrevlett.113.101101] [Citation(s) in RCA: 150] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2014] [Indexed: 06/03/2023]
Abstract
A search for high-energy neutrinos interacting within the IceCube detector between 2010 and 2012 provided the first evidence for a high-energy neutrino flux of extraterrestrial origin. Results from an analysis using the same methods with a third year (2012-2013) of data from the complete IceCube detector are consistent with the previously reported astrophysical flux in the 100 TeV-PeV range at the level of 10(-8) GeV cm-2 s-1 sr-1 per flavor and reject a purely atmospheric explanation for the combined three-year data at 5.7σ. The data are consistent with expectations for equal fluxes of all three neutrino flavors and with isotropic arrival directions, suggesting either numerous or spatially extended sources. The three-year data set, with a live time of 988 days, contains a total of 37 neutrino candidate events with deposited energies ranging from 30 to 2000 TeV. The 2000-TeV event is the highest-energy neutrino interaction ever observed.
Collapse
|
|
11 |
150 |
22
|
Kebreab E, Clark K, Wagner-Riddle C, France J. Methane and nitrous oxide emissions from Canadian animal agriculture: A review. CANADIAN JOURNAL OF ANIMAL SCIENCE 2006. [DOI: 10.4141/a05-010] [Citation(s) in RCA: 148] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Considerable evidence of climate change associated with emissions of greenhouse gases (GHG) has resulted in international efforts to reduce GHG emissions. The agriculture sector contributes about 8% of GHG emissions in Canada mostly through methane (CH4) and nitrous oxide (N2O). The objective of this paper was to compile an integrative review of CH4 and N2O emissions from livestock by taking a whole cycle approach from enteric fermentation to manure treatment and storage, and field application of manure. Basic microbial processes that result in CH4 production in the rumen and hindgut of animals were reviewed. An overview of CH4 and N2O production processes in manure, and controlling factors are presented. Most of the studies conducted in relation to enteric fermentation were in dairy and beef cattle. To date, research has focussed on GHG emissions from the stored manures of dairy, beef cattle and swine; therefore, we focus our review on these. Several methods used to measure GHG emissions from livestock and stored manure were reviewed. A comparison of methods showed that there were agreements between most of the techniques but some systematic differences were also observed. Additional studies with comprehensive comparisons of methodologies are needed in order to allow for comparison of results obtained from studies using contrasting methodologies. The need to standardize measurement methods and reporting to facilitate comparison of results and data integration was identified. Prediction equations are often used to calculate GHG emissions. Various types of mathematical approaches, such as statistical models, mechanistic models and estimates calculated from emission factors, and studies that compare various types of models are discussed herein. A lack of process-based models describing GHG emissions from manure during storage was identified. A brief description of mitigation strategies focussing on recent studies is given. Reduction in CH4 emissions from ruminants through the addition of fats in diets and the use of more starch was achieved and a transient beneficial effect of ionophores was reported. Grazing management and genetic selection also hold promise. Studies focussed on manure treatment options that thave been suggested to reduce gas fluxes from manure storage, composting, anaerobic digestion (AD), diet manipulation, covers and solid-liquid separation, were reviewed. While some of these options have been shown to decrease GHG emissions from stored manure, different studies have obtained conflicting results, and additional research is needed to identify the most promising options. GHG emissions from pasture and croplands after manure application have been the subject of several experimental and modelling studies, but few of these have linked field emissions to diet manipulation or manure treatments. Further work focussing on the entire cycle of GHG formation from feed formulation, animal metabolism, excreta treatment and storage, to field application of manure needs to be conducted. Key words: Greenhouse gases, enteric methane, nitrous oxide, manure management
Collapse
|
|
19 |
148 |
23
|
Whiteway MS, Wu C, Leeuw T, Clark K, Fourest-Lieuvin A, Thomas DY, Leberer E. Association of the yeast pheromone response G protein beta gamma subunits with the MAP kinase scaffold Ste5p. Science 1995; 269:1572-5. [PMID: 7667635 DOI: 10.1126/science.7667635] [Citation(s) in RCA: 148] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The mating response pathway of the yeast Saccharomyces cerevisiae includes a heterotrimeric guanine nucleotide-binding protein (G protein) that activates a mitogen-activated protein MAP kinase cascade by an unknown mechanism. An amino-terminal fragment of the MAP kinase scaffold protein Ste5p that interfered with pheromone-induced cell cycle arrest was identified. A haploid-specific interaction between the amino terminus of Ste5p and the G protein beta subunit Ste4p was also detected in a two-hybrid assay, and the product of a signaling-defective allele of STE4 was defective in this interaction. In cells with a constitutively activated pheromone response pathway, epitope-tagged Ste4p was coimmunoprecipitated with Ste5p. Thus, association of the G protein and the MAP kinase cassette via the scaffolding protein Ste5p may transmit the G protein signal.
Collapse
|
|
30 |
148 |
24
|
|
Review |
52 |
141 |
25
|
Clark K, Lam LT, Gibson S, Currow D. The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials. Anaesthesia 2009; 64:652-7. [DOI: 10.1111/j.1365-2044.2008.05861.x] [Citation(s) in RCA: 139] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
|
16 |
139 |